CLINICAL_TRIALS
ClinicalTrials.gov record update
STRONG Trial - Stem Cell Radiotherapy (ScRT) and Temozolomide for Newly Diagnosed High-grade Glioma (HGG): A Prospective, Phase I/II Trial
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT02039778
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:32.991508+00:00
- Published At
- 2017-06-05T00:00:00+00:00
- Record Updated At
- 2017-06-05
- Results Posted At
- 2017-06-05
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Glioblastoma", "Malignant Glioma", "Brain Tumors", "Anaplastic Astrocytoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-06-05"- protocolSection.identificationModule.nctId
"NCT02039778"- protocolSection.identificationModule.officialTitle
"STRONG Trial - Stem Cell Radiotherapy (ScRT) and Temozolomide for Newly Diagnosed High-grade Glioma (HGG): A Prospective, Phase I/II Trial"- protocolSection.statusModule.overallStatus
"TERMINATED"- protocolSection.designModule.phases
["NA"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-06-05"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.